UNC Health Medication Formulary
Add Formweb to your mobile device
UNC Health Medication Formulary
Search results for:
irinotecan
irinotecan
- Hazardous Drugs System Hazardous Drugs List Link
- Specialty Pharmacy Products Available at UNC SSC Specialty Pharmacy
- Look Alike/Sound Alike System LASA Drugs List Link
| Drug Name | Form | Strength | ARHS | Blue Ridge | Caldwell | Chatham | Johnston | Lenoir | Medical Center | Nash | Pardee | Rex | Rockingham | Southeastern | Wayne | Youth Behavioral Health |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Irinotecan Liposomal | SOLUTION, INTRAVENOUS | 4.3 mg/mL (43 mg/10 mL) | ||||||||||||||
| Irinotecan | SOLUTION, INTRAVENOUS | 20 mg/mL (5 mL) | ||||||||||||||
| Irinotecan | SOLUTION, INTRAVENOUS | 20 mg/mL (15 mL) | ||||||||||||||
| Irinotecan | SOLUTION, INTRAVENOUS | 20 mg/mL (2 mL) |
Last updated: Jun. 18, 2024
- Black Box Warning: Severe diarrhea
UNC Health
Caution – Category 1: Antineoplastic Hazardous Medication, see below for exposure mitigation strategies
System Formulary Restriction:
Use of irinotecan liposomal injection (Onivyde) is restricted to outpatient encounters or clinic use only (ie, no inpatient use) for patients who meet one of the following criteria:
Liposomal irinotecan orders must be signed by a Hematology/Oncology Attending Physician
Management of Chemotherapeutic or Hazardous Intravenous Extravasations Formulary Fact Sheet
Med Center
UNC Medical Center Formulary Restrictions
Rex
Rex Hematology-Oncology Formulary Restrictions